首页 | 本学科首页   官方微博 | 高级检索  
     

阿托伐他汀对心力衰竭患者心功能的影响
引用本文:沈桂彬,张丽华. 阿托伐他汀对心力衰竭患者心功能的影响[J]. 临床医学, 2013, 33(8): 18-19
作者姓名:沈桂彬  张丽华
作者单位:沈桂彬 (郑州市第七人民医院,郑州,450016); 张丽华 (郑州大学第二附属医院心血管内科);
摘    要:
目的 观察阿托伐他汀对心力衰竭患者心功能的影响.方法 将66例心力衰竭患者随机分为对照组和治疗组(阿托伐他汀组),在治疗前和治疗后2个月评价NHYA心功能,心脏彩超测定左室射血分数(LVEF)、左室舒张末期内径(LVEDD),测定血浆N末端脑利钠肽(NT-proBNP) 及C-反应蛋白(CRP)水平.结果 与对照组治疗后相比,阿托伐他汀组NYHA心功能分级下降,NT-proBNP及CRP水平下降,LVEF增加及LVEDD降低.结论 阿托伐他汀通过抑制心脏重构、减轻炎症反应而对心力衰竭患者有益.

关 键 词:阿托伐他汀  血浆N末端脑利钠肽  C-反应蛋白  心力衰竭

Effect of atorvastatin on cardiac function in patients with heart failure
SHEN Gui-bin,ZHANG Li-hua. Effect of atorvastatin on cardiac function in patients with heart failure[J]. Clinical Medicine, 2013, 33(8): 18-19
Authors:SHEN Gui-bin  ZHANG Li-hua
Affiliation:1) The Seventh People’s Hospital of Zhengzhou,Zhengzhou 450016,China;2) Department of Cardiology,the Second Affiliated Hospital of Zhengzhou University
Abstract:
Objective To observe the effect of atorvastatin on cardiac function in patients with heart failure. Methods Six- ty-six patients with heart failure were randomly divided into control group and treatment group (atorvastatin group), NHYA cardi- ac function, echocardiography determination of left ventricular ejection fraction (LVEF) , left ventricular end-diastolic diameter (LVEDD) were evaluated and plasma N-terminal brain natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) levels were determined before treatment and two months after treatment. Results Compared with the control group after treatment, NY- HA cardiac function grade decline, NT-proBNP and CRP level decreased and LVEF increased and LVEDD reduction in treatment group. Conclusion Atorvastatin benefit patients with heart failure by reducing the inflammatory response and inhibiting cardiac remodeling.
Keywords:Atorvastatin  N-terminal brain natriuretic peptide  C-reactive protein  Heart failure
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号